GENEVA, April 6 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/059785) for "COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF" on Sep 29, 2025. With publication no. WO/2026/069246, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CZABANIUK, Lara C. (Novartis Institutes for Biomedical Research, Inc.250 Massachusetts AvenueCambridge, Massachusetts 02139), HEDIGER, Michael Christoph (Novartis Pharma AGLichtstrasse 354056 Basel), HURTH, Konstanze (Novartis Pharma AGLichtstrasse 354056 Basel), J...